Kenneth B. Ain

9.2k total citations · 2 hit papers
78 papers, 6.9k citations indexed

About

Kenneth B. Ain is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Molecular Biology. According to data from OpenAlex, Kenneth B. Ain has authored 78 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in Kenneth B. Ain's work include Thyroid Cancer Diagnosis and Treatment (45 papers), Thyroid Disorders and Treatments (15 papers) and Cancer-related Molecular Pathways (11 papers). Kenneth B. Ain is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (45 papers), Thyroid Disorders and Treatments (15 papers) and Cancer-related Molecular Pathways (11 papers). Kenneth B. Ain collaborates with scholars based in United States, Canada and Australia. Kenneth B. Ain's co-authors include James D. Brierley, Paul W. Ladenson, S. Thomas Bigos, Samuel Refetoff, Jacob Robbins, Gopalakrishnan M. Venkataraman, Steven I. Sherman, Harry R. Maxon, Bryan R. Haugen and Douglas S. Ross and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Kenneth B. Ain

77 papers receiving 6.7k citations

Hit Papers

American Thyroid Association Guidelines for Management of... 2006 2026 2012 2019 2012 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenneth B. Ain United States 40 5.2k 1.7k 1.6k 1.5k 1.2k 78 6.9k
Matthew D. Ringel United States 55 5.1k 1.0× 1.7k 1.0× 3.6k 2.3× 2.1k 1.4× 1.3k 1.1× 176 9.1k
Andrea Lania Italy 41 3.4k 0.6× 1.3k 0.8× 1.7k 1.0× 593 0.4× 758 0.6× 274 6.0k
Françoise Borson‐Chazot France 46 3.4k 0.7× 1.7k 1.0× 568 0.4× 1.4k 0.9× 489 0.4× 227 6.0k
Klaus Kaserer Austria 40 1.8k 0.4× 1.3k 0.8× 722 0.4× 1.3k 0.9× 388 0.3× 108 4.4k
Janete M. Cerutti Brazil 32 2.1k 0.4× 773 0.5× 1.3k 0.8× 687 0.5× 576 0.5× 102 3.7k
Tsuneo Imai Japan 31 1.4k 0.3× 994 0.6× 948 0.6× 645 0.4× 617 0.5× 127 3.3k
Anders Molven Norway 46 1.5k 0.3× 2.9k 1.8× 3.2k 2.0× 1.5k 1.1× 2.5k 2.1× 168 7.0k
Robert S. Bar United States 37 2.0k 0.4× 986 0.6× 2.2k 1.3× 372 0.3× 793 0.7× 94 5.0k
Ambrogio Fassina Italy 41 1.6k 0.3× 1.6k 0.9× 1.6k 1.0× 897 0.6× 258 0.2× 173 5.3k
S. W. J. Lamberts Netherlands 32 2.4k 0.5× 835 0.5× 440 0.3× 677 0.5× 368 0.3× 77 3.9k

Countries citing papers authored by Kenneth B. Ain

Since Specialization
Citations

This map shows the geographic impact of Kenneth B. Ain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth B. Ain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth B. Ain more than expected).

Fields of papers citing papers by Kenneth B. Ain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth B. Ain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth B. Ain. The network helps show where Kenneth B. Ain may publish in the future.

Co-authorship network of co-authors of Kenneth B. Ain

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth B. Ain. A scholar is included among the top collaborators of Kenneth B. Ain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth B. Ain. Kenneth B. Ain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sherman, Steven I., Youngju Pak, Danielle R. Litofsky, et al.. (2020). The De Novo Detection of Anti-Thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence. Thyroid. 30(10). 1490–1495. 14 indexed citations
2.
McLeod, Donald S.A., David S. Cooper, Paul W. Ladenson, et al.. (2013). Prognosis of Differentiated Thyroid Cancer in Relation to Serum Thyrotropin and Thyroglobulin Antibody Status at Time of Diagnosis. Thyroid. 24(1). 35–42. 103 indexed citations
3.
Alapat, Daisy, Kenneth B. Ain, David Sloan, Kristin G. Monaghan, & Rouzan G. Karabakhtsian. (2011). Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma. Endocrine. 39(2). 148–152. 27 indexed citations
4.
Ain, Kenneth B.. (2006). Pathobiology of Antineoplastic Therapy in Undifferentiated Thyroid Cancer. Kluwer Academic Publishers eBooks. 122. 357–367. 3 indexed citations
5.
Whitley, Ronald J. & Kenneth B. Ain. (2004). Thyroglobulin: a specific serum marker for the management of thyroid carcinoma. Clinics in Laboratory Medicine. 24(1). 29–47. 45 indexed citations
6.
Xu, Xiulong, Roderick M. Quiros, Justin B. Maxhimer, et al.. (2003). Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.. PubMed. 9(16 Pt 1). 5968–79. 39 indexed citations
7.
Yatin, Servet, Mustafa Yatin, S. Varadarajan, Kenneth B. Ain, & D. Allan Butterfield. (2001). Role of spermine in amyloid ?-peptide-associated free radical-induced neurotoxicity. Journal of Neuroscience Research. 63(5). 395–401. 80 indexed citations
8.
Ain, Kenneth B., et al.. (2000). Treatment of Anaplastic Thyroid Carcinoma with Paclitaxel: Phase 2 Trial Using Ninety-Six-hour Infusion. Thyroid. 10(7). 587–594. 224 indexed citations
9.
Ain, Kenneth B.. (2000). Management of undifferentiated thyroid cancer. Best Practice & Research Clinical Endocrinology & Metabolism. 14(4). 615–629. 43 indexed citations
10.
Ain, Kenneth B.. (2000). Unusual Types of Thyroid Cancer. Reviews in Endocrine and Metabolic Disorders. 1(3). 225–231. 7 indexed citations
12.
Venihaki, Maria, Kenneth B. Ain, Eleftheria‐Kleio Dermitzaki, Achille Gravanis, & Andrew N. Margioris. (1998). KAT45, a Noradrenergic Human Pheochromocytoma Cell Line Producing Corticotropin-Releasing Hormone*. Endocrinology. 139(2). 713–722. 31 indexed citations
14.
Venkataraman, Gopalakrishnan M., Mustafa Yatin, & Kenneth B. Ain. (1998). Cloning of the Human Sodium-Iodide Symporter Promoter and Characterization in a Differentiated Human Thyroid Cell Line, KAT-50. Thyroid. 8(1). 63–69. 54 indexed citations
15.
Davey, Diane D., et al.. (1998). Assessment of fine-needle aspiration sampling technique in thyroid nodules. Diagnostic Cytopathology. 18(1). 76–80. 22 indexed citations
16.
Boghaert, Erwin R., et al.. (1996). Quantitative and qualitative differences in growth, invasion and lung colonization of an anaplastic and a papillary human thyroid cancer cell linein vitro andin vivo. Clinical & Experimental Metastasis. 14(5). 440–450. 7 indexed citations
17.
Ain, Kenneth B., Frank Pucino, György Csákó, et al.. (1996). Effects of Restricting Levothyroxine Dosage Strength Availability. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(6). 1103–1110. 4 indexed citations
18.
Smith, Charles D. & Kenneth B. Ain. (1995). Brain metabolism in hypothyroidism studied with 31P magnetic-resonance spectroscopy. The Lancet. 345(8950). 619–620. 39 indexed citations
19.
Smith, Charles D., et al.. (1994). Systemic Embolism in Thyrotoxicosis without Cardiac Arrhythmia. Thyroid. 4(2). 209–211. 2 indexed citations
20.
Sarne, David, S Sobieszczyk, Kenneth B. Ain, & Samuel Refetoff. (1990). Serum Thyrotropin and Prolactin in the Syndrome of Generalized Resistance to Thyroid Hormone: Responses to Thyrotropin-Releasing Hormone Stimulation and Short Term Triiodothyronine Suppression*. The Journal of Clinical Endocrinology & Metabolism. 70(5). 1305–1311. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026